188 related articles for article (PubMed ID: 16596744)
21. The microeconomics of personalized medicine: today's challenge and tomorrow's promise.
Davis JC; Furstenthal L; Desai AA; Norris T; Sutaria S; Fleming E; Ma P
Nat Rev Drug Discov; 2009 Apr; 8(4):279-86. PubMed ID: 19300459
[TBL] [Abstract][Full Text] [Related]
22. Towards a reconciliation between molecular diagnostics and new pharmaceuticals.
Gold B
Drug Discov Today; 2002 Oct; 7(20):1034-5. PubMed ID: 12546889
[No Abstract] [Full Text] [Related]
23. Is there a best strategy for drug discovery?--SMR Meeting. 13 March 2003, London, UK.
Lunec A
IDrugs; 2003 May; 6(5):454-7. PubMed ID: 12841215
[TBL] [Abstract][Full Text] [Related]
24. Transforming the FDA in the age of personalized medicine-interview with Ray Woosley.
Musgrave E
Clin Transl Sci; 2008 May; 1(1):5. PubMed ID: 20443811
[No Abstract] [Full Text] [Related]
25. -Omics dreams of personalized healthcare.
Nicholson JK
J Proteome Res; 2006 Sep; 5(9):2067, 2069. PubMed ID: 16969945
[No Abstract] [Full Text] [Related]
26. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
27. Molecular diagnostics as a predictive tool: genetics of drug efficacy and toxicity.
Johnson JA; Evans WE
Trends Mol Med; 2002 Jun; 8(6):300-5. PubMed ID: 12067617
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenomics: integration into drug discovery and development.
Johnson K; Thompson J; Power A
Curr Top Med Chem; 2005; 5(11):1039-46. PubMed ID: 16181129
[TBL] [Abstract][Full Text] [Related]
29. The future of pharmaceutical manufacturing in the context of the scientific, social, technological and economic evolution.
Stegemann S
Eur J Pharm Sci; 2016 Jul; 90():8-13. PubMed ID: 26542345
[TBL] [Abstract][Full Text] [Related]
30. Big gene banks: nuggets for drug discovery or fool's gold?
Louis JC
Drug Discov Today; 2003 Feb; 8(3):100-1. PubMed ID: 12568772
[TBL] [Abstract][Full Text] [Related]
31. Getting to personalized cancer medicine: taking out the garbage.
Compton C
Cancer; 2007 Oct; 110(8):1641-3. PubMed ID: 17763370
[No Abstract] [Full Text] [Related]
32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
33. Drug evaluation, drug development and pharmacogenetics: celebrating 30 years of progress.
Li Wan Po A
J Clin Pharm Ther; 2005 Feb; 30(1):1-4. PubMed ID: 15658998
[No Abstract] [Full Text] [Related]
34. A pharmacogeneticist's look at drug effects and the drug development process: an overview.
Kalow W
Expert Opin Pharmacother; 2005 Jul; 6(8):1299-303. PubMed ID: 16013980
[TBL] [Abstract][Full Text] [Related]
35. Toxicogenomics: an opportunity to optimise drug development and safety evaluation.
Kramer JA; Kolaja KL
Expert Opin Drug Saf; 2002 Sep; 1(3):275-86. PubMed ID: 12904143
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in the pharmacogenetics of cancer chemotherapy.
Watters JW; McLeod HL
Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
Yan L; Beckman R
Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
[TBL] [Abstract][Full Text] [Related]
38. Applying the genome to national drug formulary policy in the developing world.
Roederer MW; McLeod HL
Pharmacogenomics; 2010 May; 11(5):633-6. PubMed ID: 20415551
[TBL] [Abstract][Full Text] [Related]
39. Next revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine.
Bissonnette L; Bergeron MG
Expert Rev Mol Diagn; 2006 May; 6(3):433-50. PubMed ID: 16706745
[TBL] [Abstract][Full Text] [Related]
40. [Companion diagnostics: significances and issues in its clinical application].
Miyachi H
Rinsho Byori; 2011 Jun; 59(6):602-9. PubMed ID: 21815484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
